Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Latest News Releases
Updates every hour. Last Updated: 30-Oct-2026 03:16 ET (30-Oct-2026 07:16 GMT/UTC)
Researchers identify a key biological tipping point in Alzheimer’s disease
Vlaams Instituut voor BiotechnologiePeer-Reviewed Publication
- Journal
- Nature Medicine
- Funder
- Muna Therapeutics, VIB, KU Leuven, ERC, UK DRI, FWO, Stichting Alzheimer Onderzoek
Air pollution may be harming your brain’s ‘encyclopedia’
University of California - Davis HealthPeer-Reviewed Publication
- Journal
- Alzheimer s & Dementia Behavior & Socioeconomics of Aging
Allen Institute launches Brain Health Accelerator to transform our understanding of brain disorders and develop new treatments
Allen InstituteBusiness Announcement
- Funder
- Fund for Science and Technology
New reference map of the brain may transform how scientists detect disease
Keck School of Medicine of USCPeer-Reviewed Publication
- Journal
- Nature Communications
- Funder
- Alzheimer's Association, European Research Council, Wellcome Trust
Gladstone investigator Andrew Yang receives 2026 Sobrato Prize in Neuroscience
Gladstone InstitutesGrant and Award Announcement
This year’s recipient of the Sobrato Prize in Neuroscience is Andrew Yang, PhD, whose research has reshaped scientific understanding of the blood-brain barrier and its role in brain health and disease. Yang is an investigator at the Gladstone Institute of Neurological Disease and an assistant professor of neurology and anatomy at the University of California, San Francisco. Launched in 2024, the Sobrato Prize in Neuroscience seeks to bridge the gap between discovery and the clinic, accelerating life-changing brain science with high potential for patient impact. It is awarded to scientists at Gladstone Institutes whose research has a particularly high potential to lead to new therapies for major brain diseases.